-
Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol
Schaeffers, A. W. M. A., Devriese, L. A., van Gils, C. H., Dankbaar, J. W., Voortman, J., de Boer, J. P., Slingerland, M., Hendriks, M. P., Smid, E. J., Frederix, G. W. J. & de Bree, R., Nov 2023, In: PLOS ONE. 18, 11 November, p. e0294147 e0294147.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
